Dr. Lydia Marie Kasper, DO

Dr. Kasper practices at Jersey City Medical Center in Jersey City, New Jersey, part of RWJBarnabas Health.

Dr. Kasper's NPI, 1134420565, was assigned on November 17, 2010. Dr. Kasper graduated from New York College of Osteo Medicine of New York Institute of Technology in 2010. Dr. Kasper holds New Jersey license 25MB09297800.

Dr. Kasper's primary practice is Jersey City Medical Center, at 355 Grand Street, Jersey City, NJ 07302 in Hudson County. The practice phone is (201) 915-2000.

Dr. Kasper's primary practice is Jersey City Medical Center in Jersey City, New Jersey, part of RWJBarnabas Health. Dr. Kasper is also affiliated with Englewood Hospital. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Kasper to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kasper practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Kasper's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Kasper is licensed in New Jersey.

CMS data shows 340 Medicare services from Dr. Kasper across 7 procedure codes in 2024, for 283 Medicare patients. Medicare paid $42,090 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 283 Medicare patients who saw Dr. Kasper in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kasper's median patient age at 64, with 58% women.

In 2024, Dr. Kasper wrote 33 Medicare Part D claims for 26 patients. 85% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $98 in total drug cost. In 2018, CMS named 34 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kasper for performance year 2024, reported as part of a group. Dr. Kasper accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 38 papers to Dr. Kasper, published from 2013 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Candida albicans, Macrophages and Fungal Proteins. Dr. Kasper has published most often in mBio. Dr. Kasper's most frequent co-authors are David Brian Corry, MD, Albert Haas, MD and Farrah Kheradmand, MD.

CMS Open Payments shows 8 general payments to Dr. Kasper from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $172.

Dr. Kasper graduated from New York College of Osteo Medicine of New York Institute of Technology in 2010.